Gralise ER 600 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F9AL4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,672
Award facts
- Contract value 100% obligated
- $18,671.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,671.71 to AmerisourceBergen Drug Corp for the supply of Gralise ER 600 mg tablets (90-count units). This firm fixed-price, non-set-aside contract was awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gralise is a gabapentin formulation used for the management of post-herpetic neuralgia and other neuropathic pain conditions, representing a routine pharmaceutical procurement to support federal healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated the capability to meet competitive federal requirements across diverse therapeutic domains through this expansive contract framework.
Quick answers
Who was awarded contract SPE2DR26F9AL4?
SPE2DR26F9AL4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26F9AL4 worth?
The government has obligated $18,672 on SPE2DR26F9AL4.
Is contract SPE2DR26F9AL4 an order under another contract?
Yes. SPE2DR26F9AL4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AL4 competed?
The extent of competition for SPE2DR26F9AL4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award